Pulsara Around the World - October 2025
September Recap The weather may (finally) be cooling off, but our autumn event season is bringing the heat. 12 down in September and another 12 on...
1 min read
Brittney Nelson, BSN, RN, SCRN
:
Feb 25, 2019
Target: Stroke, launched in 2010 by the American Heart Association, was a quality improvement initiative aimed at helping stroke centers reduce their door-to-needle treatment times.
At the 2019 International Stroke Conference, the AHA released phase III, which will give facilities the ability to be recognized for their efforts of faster door-to-needle times while also giving first-ever goals for Endovascular Treatment. Facilities who meet the new Phase III requirements will have the ability to be recognized starting in 2020.
Does your facility have a plan for meeting the new phase III goals?
If not, Pulsara should be your answer! Did you know the #1 reason for delayed treatment is communication breakdown? At Pulsara, we pride ourselves on our ability to place entire teams on the same communication channel - which research shows decreases treatment times and can help reduce medical errors secondary to miscommunication.
For more information on Target: Stroke Phase III click HERE
To find out how Pulsara can help YOU decrease treatment times at your facility and get you one step closer to meeting Target: Stroke Phase III Goals click HERESeptember Recap The weather may (finally) be cooling off, but our autumn event season is bringing the heat. 12 down in September and another 12 on...
How an Arkansas hospital improved their door-to-needle benchmark success rates across the board and achieved a record treatment time of 18 minutes. ...
Editor's Note: In May 2025, FireRescue1 released their annual digital edition, Fire Command Ready: Building Bench Strength, proudly sponsored by...